-Reuters
Gillette Maker Procter & Gamble Q2 Earnings Top Estimates
Procter & Gamble Co (NYSE:PG) reported second-quarter FY22 sales growth of 6.12% year-on-year, to $20.95 billion, beating the analyst consensus of…
Related Posts
Morgan Stanley Initiates Coverage On Oatly Group with Equal-Weight Rating, Announces Price Target of $29
Morgan Stanley analyst Dara Mohsenian initiates coverage on Oatly Group (NASDAQ:OTLY) with a Equal-Weight rating and announces Price Target of $29.
DA Davidson Initiates Coverage On Nikola with Neutral Rating, Announces Price Target of $10
DA Davidson analyst Michael Shlisky initiates coverage on Nikola (NASDAQ:NKLA) with a Neutral rating and announces Price Target of $10.
Revolution Medicines Reports Progress Across Pipeline Of Targeted Therapeutics For RAS-Addicted Cancers
Revolution Medicines, Inc. (NASDAQ:RVMD), a clinical-stage oncology company developing novel targeted therapies for RAS-addicted cancers, today reported progress across its pipeline of targeted therapeutics spanning its